Journal of Renal Nutrition
Volume 11, Issue 4 , Pages 207-211 , October 2001

Changes in serum leptin levels in chronic renal failure patients with metabolic acidosis

References 

  1. Zhang Y, Proenca R, Maffei M, et al.  Positional cloning of the mouse obese gene and its human homologue. Nature. 1994;372:425–432
  2. Stephens TW, Basinsk IM, Bristow PK, et al.  The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature. 1995;377:530–532
  3. Stenvinkel P. Leptin—A new hormone of definite interest for the nephrologist. Nephrol Dial Transplant. 1998;13:1099–1101
  4. Sharma K, Considine R. The OB protein (leptin) and the kidney. Kidney Int. 1998;53:1483–1487
  5. Nordfors L, Lonnqvist F, Heimburger O, et al.  Low leptin gene expression and hyperleptinemia in chronic renal failure. Kidney Int. 1998;54:1267–1275
  6. Ikizler TA, Hakim RM. Nutrition in end-stage renal disease. Kidney Int. 1996;50:343–357
  7. Ikizler TA, Wingard RL, Suw M, et al.  Increased energy expenditure in hemodialysis patients. J Am Soc Nephrol. 1996;7:2646–2653
  8. Roberts RG, Gilmour ER, Goodship TH. The correction of acidosis does not increase dietary protein intake in chronic renal failure patients. Am J Kidney Dis. 1996;28:353–355
  9. Daschner M, Tonshoff B, Blum WF, et al.  Inappropriate elevation of serum leptin levels in children with chronic renal failure. J Am Soc Nephrol. 1998;9:1074–1079
  10. Howard JK, Lord GM, Clutterrbuck EJ, et al.  Plasma imnunoreactive leptin concentration in end-stage renal disease. Clin Sci. 1997;93:119–126
  11. Landt M, Martin DR, Zeng J, et al.  Plasma leptin concentrations are only transiently increased in nephrectomized rats. Am J Physiol. 1998;275:E495–E499
  12. Cumin F, Baum H, Levens N. Leptin is cleared from the circulation primarily by the kidney. Int J Obesity. 1996;20:1120–1126
  13. Mercer JG, Hoggard N, Williams LM, et al.  Localization of leptin receptor mRNA and the long form splice variant (Ob-Rb) in mouse hypothalamus and adjacent brain regions by in situ hybridization. FEBS Lett. 1996;387:113–116
  14. Mondal M, Nakazato M, Date Y, et al.  Characterization of orexin-A and orexin-B in the microdissected rat brain nuclei and their contents in two obese rat models. Neurosci Lett. 1999;273:45–48
  15. Kokot F, Adamczak M, Wiecek A, et al.  Plasma leptin concentration in kidney transplant patients during the early post-transplant period. Nephrol Dial Transplant. 1998;13:2276–2280
  16. Nishikawa M, Takagi T, Yoshikawa N, et al.  Measurement of serum leptin in patients with chronic renal failure on hemodialysis. Clin Nephrol. 1999;51:296–303
  17. Uehara Y, Shimizu H, Ohtani KI, et al.  Hypothalamic corticotropin-releasing hormone is a mediator of the anorexigenic effect of leptin. Diabetes. 1998;47:890–893
  18. Kolaczyriski JM, Nyce MR, Considine RV, et al.  Acute and chronic effect of insulin on leptin production in humans. Diabetes. 1996;45:699–701
  19. Stenvinkel P, Heimburger O, Lonnqicist F. Serum leptin concentrations correlate to plsma insulin concentrations independent of body fat content in chronic renal failure. Nephrol Dial Transplant. 1997;12:1321–1325
  20. Kokt F, Wiecek A, Mesjasz J, et al.  Influence of long-term recombinant human erythropoietin(rHuEPO) therapy on plasma leptin and neuropeptide Y concentration in haemodialysed uraemic patients. Nephrol Dial Transplant. 1998;13:1200–1205

☆ Address reprint requests to Falei Zheng, MD, Division of Nephrology, Peking Union Medical College Hospital, Shuai-Fu-Yuan St, Beijing 100730, China.

PII: S1051-2276(01)70039-8

doi: 10.1016/S1051-2276(01)70039-8

Journal of Renal Nutrition
Volume 11, Issue 4 , Pages 207-211 , October 2001

Article Tools